Edgewell Personal Care Company (NYSE:EPC) Q3 2023 Results Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Chris Gough - Vice President-Investor Relations Rod Little - President and Chief Executive Officer Daniel Sullivan - Chief Financial Officer and President, Europe and Latin America Conference Call Participants Nik Modi - RBC Capital Markets William Chappell - Truist Securities Christopher Carey - Wells Fargo Securities Susan Anderson - Canaccord Genuity Olivia Tong - Raymond Jame ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 10-Q _______________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission File Number: 001-15401 _____________________________________ ...

Edgewell Personal Care Company (NYSE:EPC) Q2 2023 Earnings Conference Call May 9, 2023 8:00 AM ET Company Participants Chris Gough – Vice President-Investor Relations Rod Little – President and Chief Executive Officer Dan Sullivan – Chief Financial Officer Conference Call Participants Chris Carey – Wells Fargo Securities Susan Anderson – Canaccord Genuity Peter Grom – UBS Bill Chappell – Truist Securities Kevin Grandy – Jefferies Jason English – Goldman Sachs Devin Weinstein – Raymond James Operator Good mo ...

Financial Performance - Net sales for the first six months of fiscal 2023 increased 5.6% to $1,067.5 million, with organic net sales rising 7.6% compared to the prior year period [102]. - Net sales in the second quarter of fiscal 2023 increased 9.3% to $598.4 million, with organic net sales up 11.4% driven by increased pricing and volumes [102]. - Net earnings in the second quarter of fiscal 2023 were $19.0 million, down from $23.2 million in the prior year quarter, while adjusted net earnings increased to $29.0 million from $27.0 million [102]. - Net earnings for the first six months of fiscal 2023 were $30.9 million, down from $34.4 million in the prior year period, with adjusted net earnings at $45.0 million compared to $50.2 million [104]. - Gross profit for the second quarter of fiscal 2023 was reported at $241.7 million, with a GAAP effective tax rate of 26.9% [101]. - Gross profit for the first six months of fiscal 2023 was $430.7 million, compared to $420.0 million in the prior year, with a gross margin of 40.3% versus 41.5% [108]. Expenses and Costs - Selling, General and Administrative (SG&A) expenses for the first six months of fiscal 2023 were $200.9 million, or 18.8% of net sales, compared to $198.2 million, or 19.6% of net sales in the prior year [110]. - Advertising and promotion expense for the first six months of fiscal 2023 was $108.8 million, a decrease of $7.3 million from the prior year, with A&P as a percent of net sales at 10.2% compared to 11.5% [112]. - Research and development expense for the first six months of fiscal 2023 was $27.8 million, maintaining 2.6% of net sales, consistent with the prior year [113]. - Interest expense associated with debt for the first six months of fiscal 2023 was $40.6 million, up from $35.3 million in the prior year, due to higher interest rates and increased debt [115]. - The effective tax rate for the first six months of fiscal 2023 was 27.0%, compared to 20.5% in the prior year, reflecting an unfavorable mix of earnings in higher tax rate jurisdictions [117]. Acquisitions and Impact - The acquisition of Billie, Inc. was completed on November 29, 2021, for a purchase price of $309.4 million [98]. - Organic net sales will be negatively impacted in October and November of fiscal 2023 due to the Billie acquisition, as sales previously reported as third-party sales are now inter-company sales [91]. - Net sales for the first six months of fiscal 2023 were $1,067.5 million, an increase of 5.6%, driven by a $12.0 million contribution from the Billie acquisition and a $32.0 million unfavorable impact from currency movements [106]. Segment Performance - Wet Shave segment profit for the first six months of fiscal 2023 was $70.5 million, a decrease of 10.9% from the prior year, despite an organic segment profit increase of 8.1% [125]. - Sun and Skin Care net sales for Q2 fiscal 2023 increased by $26.4 million, or 14.4%, with organic net sales up $27.5 million, or 15.0% [126]. - Feminine Care net sales for Q2 fiscal 2023 rose by $20.7 million, or 34.9%, with organic net sales increasing by $21.0 million, or 35.4% [131]. - Segment profit for Sun and Skin Care in Q2 fiscal 2023 was $39.9 million, a decrease of $2.4 million, or 5.6% [128]. - Segment profit for Feminine Care in Q2 fiscal 2023 was $12.0 million, an increase of $10.1 million, or 531.7% [133]. Cash Flow and Debt - Cash flow from operating activities was $1.9 million during the first six months of fiscal 2023, compared to cash used of $39.9 million in the prior year [147]. - Net cash used by investing activities was $20.0 million during the first six months of fiscal 2023, significantly lower than $325.7 million in the prior year [148]. - Total borrowings as of March 31, 2023, were $1,447.5 million, including $195.2 million tied to variable interest rates [139]. - As of March 31, 2023, the company had outstanding variable-rate debt of $195.2 million related to its Revolving Credit Facility and international notes payable [157]. - A one-percent increase in applicable interest rates would result in an approximate $2.0 million increase in annual interest expense on variable-rate debt instruments [157]. Corporate Governance and Compliance - The company utilizes non-GAAP measures to provide insights into operational results, excluding costs related to restructuring, acquisitions, and other non-standard items [90]. - The company emphasizes the importance of non-GAAP measures for internal decision-making and believes they provide more transparency for investors [90]. - The company expects to incur approximately $19 million in charges related to its operating model redesign in fiscal 2023, with $6.0 million incurred in the first six months [118]. - Corporate expenses for Q2 fiscal 2023 were $17.0 million, or 10.2% of net sales, compared to $17.2 million, or 8.2% of net sales in the prior year [135]. - As of March 31, 2023, the company was in compliance with the provisions and covenants associated with its debt agreements [144]. - There have been no open derivative or hedging instruments for future purchases of raw materials or commodities as of March 31, 2023 [157]. - The company's assessment of market risk sensitivity has not materially changed since the 2022 Annual Report [158].

Edgewell Personal Care Company (NYSE:EPC) Q1 2023 Earnings Conference Call February 8, 2023 8:00 AM ET Company Participants Chris Gough – Vice President-Investor Relations Rod Little – President and Chief Executive Officer Dan Sullivan – Chief Financial Officer Conference Call Participants Chris Carey – Wells Fargo Securities Susan Anderson – Canaccord Genuity Kevin Grundy – Jefferies Bill Chappell – Truist Securities Devin Weinstein – Raymond James Operator Good morning everyone. And welcome to the Edgewel ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 10-Q _______________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission File Number: 001-15401 _________________________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission File Number 001-15401 EDGEWELL PERSONAL CARE COMPANY (Exact name of registrant as specifie ...

Edgewell Personal Care Company (NYSE:EPC) Q4 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Chris Gough - Vice President-Investor Relations Rod Little - President & Chief Executive Officer Dan Sullivan - Chief Financial Officer Conference Call Participants Chris Carey - Wells Fargo Securities Kevin Grundy - Jefferies Nik Modi - RBC Capital Markets Bill Chappell - Truist Securities Olivia Tong - Raymond James Operator Good day, and welcome to the Edgewell Personal Care Q4 202 ...

Edgewell Personal Care Company (NYSE:EPC) Q3 2022 Results Conference Call August 4, 2022 8:00 AM ET Company Participants Rod Little - President, Chief Executive Officer & Director Chris Gough - Vice President, Investor Relations, Corporate Development & Treasury Dan Sullivan - Chief Financial Officer Conference Call Participants Olivia Tong - Raymond James Jason English - Goldman Sachs Bill Chappell - Trust Securities Nik Modi - RBC Capital Markets Kevin Grundy - Jefferies Chris Carey - Wells Fargo Securiti ...

____________________________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 10-Q _______________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr ...